Indication

Chronic granulomatous disease

Chronic granulomatous disease is a rare, inherited primary immunodeficiency disorder affecting innate immunity, most commonly diagnosed in childhood but occasionally identified in adults. Read more about Chronic granulomatous disease

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Chronic granulomatous disease therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Chronic granulomatous disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic granulomatous disease.

Chronic granulomatous disease is a rare, inherited primary immunodeficiency disorder affecting innate immunity, most commonly diagnosed in childhood but occasionally identified in adults.

It is caused by genetic defects in the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzyme complex, which impairs the respiratory burst and prevents neutrophils, monocytes, and macrophages from producing the reactive oxygen species needed for microbial killing.

Pathophysiologically, this defect leads to recurrent, life-threatening bacterial and fungal infections—particularly by catalase-positive organisms—alongside excessive, dysregulated inflammation characterized by granuloma formation and tissue damage across organ systems such as the lungs, lymph nodes, liver, skin, and gastrointestinal tract.

Personalize your experience

Follow Chronic granulomatous disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it